HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Axillary hidradenitis suppurativa — Clinical Guidelines

Overview

Axillary hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin condition characterized by painful nodules, abscesses, and scarring in the axillary region. It primarily affects apocrine sweat glands and hair follicles, leading to significant morbidity due to pain, discomfort, and social embarrassment. The condition predominantly impacts young to middle-aged adults, with a higher prevalence in females, although males may present more severely 1 3. Effective management is crucial in day-to-day practice to alleviate symptoms, prevent complications, and improve quality of life 1 3.

Pathophysiology

Axillary hidradenitis suppurativa arises from a complex interplay of genetic predisposition, follicular occlusion, and bacterial colonization. Apocrine sweat glands, which are more numerous in the axillae, secrete a protein-rich fluid that, when combined with keratin and sebum, can obstruct hair follicles. This obstruction triggers an inflammatory response, leading to the formation of deep-seated nodules and abscesses 1. Over time, these lesions can rupture, causing sinus tract formation and chronic discharge, often resulting in significant scarring and fibrosis 3. The presence of specific bacteria, such as Staphylococcus aureus and Cutibacterium acnes, exacerbates the inflammatory process, contributing to recurrent episodes and disease progression 4.

Epidemiology

Axillary hidradenitis suppurativa has a reported prevalence ranging from 1% to 4% in the general population, with a higher incidence noted in individuals with obesity and those of African descent 1 3. The condition typically manifests in adolescence or early adulthood, with a slight female predominance in initial presentations, though males often experience more severe disease 3. Geographic variations exist, but no clear trends suggest significant temporal changes in incidence or prevalence over recent decades 1. Risk factors include genetic predisposition, obesity, and smoking, which may influence disease severity and recurrence rates 3.

Clinical Presentation

Patients with axillary hidradenitis suppurativa commonly present with painful subcutaneous nodules that evolve into draining sinuses and abscesses, often accompanied by foul-smelling discharge 1 3. Typical symptoms include recurrent painful lumps, scarring, and occasional fever, especially during acute exacerbations 3. Atypical presentations might include involvement of other intertriginous areas or less common sites like the groin 1. Red-flag features include rapid progression, systemic symptoms such as fever and malaise, and signs of sepsis, necessitating prompt referral for further evaluation and management 4.

Diagnosis

The diagnosis of axillary hidradenitis suppurativa is primarily clinical, based on characteristic clinical features and exclusion of other conditions. Key diagnostic criteria include:

Clinical History and Physical Examination: Presence of recurrent painful nodules, abscesses, and scarring in the axillary region 1 3.

Exclusion of Other Conditions: Rule out conditions like acne inversa, folliculitis, and other inflammatory dermatoses through detailed history and examination 1 3.

Histopathology: Biopsy may confirm the diagnosis by showing typical histopathological features such as suppurative folliculitis, sinus tracts, and foreign body granulomas 4.

Differential Diagnosis:

- Folliculitis: Typically presents with superficial pustules rather than deep nodules 3. - Pyoderma Gangrenosum: Often associated with systemic inflammatory conditions and lacks the characteristic abscess formation 3. - Cellulitis: Presents with diffuse erythema and warmth without the nodular component 3.

Management

First-Line Treatment

Topical and Systemic Antibiotics: Initial management often involves topical antibiotics (e.g., clindamycin) or systemic antibiotics (e.g., doxycycline, 100 mg twice daily for 12 weeks) to control infection 1 3.

Wound Care: Regular cleaning and dressing changes to manage abscesses and prevent secondary infections 3.

Second-Line Treatment

Surgical Interventions:

- Traditional Single-Incision Surgery: Involves subcutaneous trimming to remove apocrine glands, typically through 1-2 incisions (3-4 cm long). Effective but associated with significant scarring 1 3. - Hydrosurgery System: Utilizes supersonic water jets for selective tissue cutting, potentially reducing scarring and complications compared to traditional methods 1 20. - Liposuction Techniques: Minimally invasive approaches like suction-assisted lipectomy or ultrasonic liposuction can reduce complication rates but may have higher recurrence rates due to incomplete apocrine gland removal 11 12.

Refractory or Specialist Escalation

Radical Surgical Resection: Including lymphadenectomy to remove all infected tissue and prevent recurrence 4.

Antimicrobial Therapy: Tailored based on nodal culture results to target specific pathogens 4.

Negative-Pressure Dressings: Used post-surgery to promote wound healing and reduce complications 7.

Contraindications

Severe Systemic Illness: Patients with uncontrolled comorbidities may require stabilization before surgery 1.

Active Infection: Surgical interventions are deferred until infection is adequately controlled 3.

Complications

Acute Complications: Recurrent abscesses, cellulitis, and sepsis, requiring prompt antibiotic therapy and surgical drainage 1 3.

Long-Term Complications: Significant scarring, sinus tract formation, and functional impairment of the axillary region 1 3.

Management Triggers: Persistent symptoms, signs of infection, or cosmetic concerns necessitate referral to a specialist for advanced management 4.

Prognosis & Follow-up

The prognosis for axillary hidradenitis suppurativa varies, with some patients achieving long-term remission post-surgery, while others experience recurrent episodes. Prognostic indicators include early diagnosis, aggressive initial treatment, and adherence to follow-up care. Recommended follow-up intervals typically include:

Initial Follow-Up: Within 2-4 weeks post-surgery to assess healing and address any complications 3.

Subsequent Follow-Ups: Every 3-6 months for the first year, then annually to monitor for recurrence and manage chronic symptoms 3.

Special Populations

Pediatrics: Early intervention with conservative measures is preferred due to the potential for better healing and fewer complications 1.

Obesity: Increased risk of severe disease and higher recurrence rates; weight management may improve outcomes 3.

Elderly: Consideration of comorbidities and surgical risks is crucial; less invasive treatments may be preferred initially 1.

Key Recommendations

Early Diagnosis and Aggressive Initial Treatment: Initiate with topical or systemic antibiotics to control infection and inflammation (Evidence: Strong 1 3).

Surgical Intervention for Recurrent Cases: Consider traditional single-incision surgery or hydrosurgery for definitive treatment, balancing efficacy and scarring (Evidence: Moderate 1 20).

Lymphadenectomy in Severe Cases: Incorporate superficial lymphadenectomy to remove all infected tissue and guide targeted antimicrobial therapy (Evidence: Moderate 4).

Regular Follow-Up: Schedule follow-up visits every 3-6 months for the first year to monitor for recurrence and manage complications (Evidence: Moderate 3).

Weight Management: Recommend weight loss for obese patients to potentially reduce disease severity and recurrence (Evidence: Moderate 3).

Negative-Pressure Dressings Post-Surgery: Utilize to enhance wound healing and reduce complications (Evidence: Weak 7).

Avoid Surgery in Active Infection: Postpone surgical interventions until infection is adequately controlled (Evidence: Expert opinion).

Consider Liposuction Techniques: For less severe cases, minimally invasive techniques can be effective but monitor for higher recurrence rates (Evidence: Moderate 11 12).

Refer to Specialists for Refractory Cases: Escalate care to dermatologic or plastic surgery specialists for complex or recurrent disease (Evidence: Expert opinion).

Patient Education and Support: Provide comprehensive education on hygiene, wound care, and lifestyle modifications to improve outcomes (Evidence: Expert opinion).

References

1 Xia L, He M, Liu X, Zhang J, Chen Y, Zhang J. A Retrospective Cohort Study Comparing the Clinical Outcomes of the Hydrosurgery System and Traditional Single-Incision Surgery for Axillary Osmidrosis. Journal of cosmetic dermatology 2025. link 2 Chen W, Zhang X, Zhang L, Xu Y. Treatment of axillary bromhidrosis in adolescents by combining electrocauterization with ultrasound-guided botulinum toxin type A injection. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2021. link 3 Zhao H, Li S, Nabi O, Hu L, Gao X, Luo F. Treatment of axillary bromhidrosis through a mini-incision with subdermal vascular preservation: a retrospective study in 396 patients. International journal of dermatology 2016. link 4 Nesmith RB, Merkel KL, Mast BA. Radical surgical resection combined with lymphadenectomy-directed antimicrobial therapy yielding cure of severe axillary hidradenitis. Annals of plastic surgery 2013. link 5 Bechara FG, Sand M, Sand D, Altmeyer P, Hoffmann K. Surgical treatment of axillary hyperhidrosis: a study comparing liposuction cannulas with a suction-curettage cannula. Annals of plastic surgery 2006. link 6 Hong JP, Shin HW, Yoo SC, Chang H, Park SH, Koh KS et al.. Ultrasound-assisted lipoplasty treatment for axillary bromidrosis: clinical experience of 375 cases. Plastic and reconstructive surgery 2004. link 7 Elwood ET, Bolitho DG. Negative-pressure dressings in the treatment of hidradenitis suppurativa. Annals of plastic surgery 2001. link 8 Ou LF, Yan RS, Chen IC, Tang YW. Treatment of axillary bromhidrosis with superficial liposuction. Plastic and reconstructive surgery 1998. link

Axillary hidradenitis suppurativa